Annual Cash & Cash Equivalents
$933.74M$354.82M+61.29%
Summary
- Current Value
- As of today, NVAX annual cash & cash equivalents is $933.74M, up +61.29% on
- Historical Performance
- NVAX annual cash & cash equivalents is down -38.84% over the past 3 years, and up +1041.92% over the past 5 years
- All-Time High Comparison
- NVAX annual cash & cash equivalents is currently -38.84% below its historical high of $1.53B set on
- 3-Year Low Comparison
- NVAX annual cash & cash equivalents is +61.29% above its 3-year low of $578.93M reached on
- Sector Comparison
- NVAX annual cash & cash equivalents is higher than 93.13% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $933.74M | +61.3% | -38.8% | +1041.9% | +2074.0% | |
| Quarterly Cash & Cash Equivalents | $773.71M | -15.9% | -40.1% | +35.5% | +1998.9% | |
| Price | $7.78 | -9.0% | -36.7% | -93.9% | -84.5% | |
| Annual Current Assets | $1.13B | -1.3% | -47.6% | +1060.9% | +2436.8% | |
| Annual Total Liabilities | $2.23B | -13.4% | -24.0% | +520.2% | +10000.0% | |
| Annual Working Capital | -$25.47M | +94.8% | +89.2% | -135.7% | -169.8% | |
| Annual Net Income | -$187.50M | +65.6% | +89.3% | -41.3% | -388.6% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.35B | N/A | -30.7% |
| 5Y | $1.53B | -38.8% | |
| All | $1.53B | -38.8% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $578.93M | +61.3% | |
| 5Y | $578.93M | +61.3% | |
| All | $700.00K | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of NVAX?
As of today, NVAX annual cash & cash equivalents is $933.74M
What is 1-year change in NVAX annual cash & cash equivalents?
NVAX annual cash & cash equivalents is up +61.29% year-over-year
What is 3-year change in NVAX annual cash & cash equivalents?
NVAX annual cash & cash equivalents is down -38.84% over the past 3 years
How far is NVAX annual cash & cash equivalents from its all-time high?
NVAX annual cash & cash equivalents is currently -38.84% below its historical high of $1.53B set on December 31, 2021
How does NVAX annual cash & cash equivalents rank versus sector peers?
NVAX annual cash & cash equivalents is higher than 93.13% of companies in Healthcare sector
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly Cash & Cash Equivalents
$773.71M$150.66M+24.18%
Summary
- Current Value
- As of today, NVAX quarterly cash & cash equivalents is $773.71M, up +24.18% on
- Historical Performance
- NVAX quarterly cash & cash equivalents is down -15.91% year-over-year, and down -40.09% over the past 3 years
- All-Time High Comparison
- NVAX quarterly cash & cash equivalents is currently -63.53% below its historical high of $2.12B set on
- 3-Year Low Comparison
- NVAX quarterly cash & cash equivalents is +57.57% above its 3-year low of $491.04M reached on
- Sector Comparison
- NVAX quarterly cash & cash equivalents is higher than 90.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $773.71M | +24.2% | -15.9% | -40.1% | +35.5% | |
| Annual Cash & Cash Equivalents | $933.74M | – | +61.3% | -38.8% | +1041.9% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| Quarterly Current Assets | $974.59M | +6.0% | -11.7% | -44.6% | +45.2% | |
| Quarterly Total Liabilities | $1.34B | +2.9% | -40.3% | -52.8% | +109.6% | |
| Quarterly Working Capital | $544.72M | +2.7% | +804.5% | +492.1% | +26.1% | |
| Quarterly Net Income | -$202.38M | -290.0% | -66.8% | -20.0% | -2.6% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $933.74M | N/A | -17.1% |
| 3Y | $1.35B | N/A | -42.6% |
| 5Y | $2.12B | -63.5% | |
| All | $2.12B | -63.5% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $623.05M | +24.2% | |
| 3Y | $491.04M | +57.6% | |
| 5Y | $491.04M | +57.6% | |
| All | $324.00K | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of NVAX?
As of today, NVAX quarterly cash & cash equivalents is $773.71M
What is NVAX quarterly cash & cash equivalents most recent change?
NVAX quarterly cash & cash equivalents was up +24.18% on September 30, 2025
What is 1-year change in NVAX quarterly cash & cash equivalents?
NVAX quarterly cash & cash equivalents is down -15.91% year-over-year
How far is NVAX quarterly cash & cash equivalents from its all-time high?
NVAX quarterly cash & cash equivalents is currently -63.53% below its historical high of $2.12B set on June 30, 2021
How does NVAX quarterly cash & cash equivalents rank versus sector peers?
NVAX quarterly cash & cash equivalents is higher than 90.44% of companies in Healthcare sector
When is NVAX next earnings release?
The next earnings release for NVAX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax